Achromobacter Xylosoxidans: Antimicrobial Therapy, Resistance Patterns, And Infection Control
Achromobacter xylosoxidans, a non-fermentative Gram-negative bacterium, is an opportunistic pathogen responsible for both nosocomial and community-acquired infections. Antimicrobial therapy is crucial for its management, with choices guided by susceptibility testing. Empirical therapy often includes antibiotics like cefepime or carbapenems, while targeted therapy considers resistance patterns. Prevention and control measures in healthcare settings aim to curb…